Search For "immunogenic"
Novo Medi Sciences Launches NEXIPOX PLUS®, a Next-Generation Varicella Vac
Updated : 4 months ago IST
Mumbai (Maharashtra) [India] January 23: Novo Medi Sciences Pvt. Ltd. (Novo Group), a legacy-driven pharmaceutical company with 80 years of expertise in developing niche biological products such as vaccines and life-saving critical care solutions, has announced the launch of NEXIPOX PLUS®, t
Read More
Expert committee approves Bharat Biotech International's proposal to condu
Updated : 2 years ago IST
The Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation (CDSCO) has approved vaccine major Bharat Biotech International's proposal to conduct the Phase II clinical trial of Mycobacterium Tuberculosis (Live Attenuated) Vaccine to assess the safety and immunogen
Read More
Researchers develop new Zika vaccine that shows promise in animal models
Updated : 3 years, 8 months ago IST
Washington [US], September 29 (ANI): Researchers have developed a Zika vaccine technology that is highly effective and safe in preclinical mouse models.
Read More
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
Govinda and Swwapnil Joshi came at the success celebration of Namma Homeop
Updated : 3 years, 11 months ago IST
Mumbai (Maharashtra) [India], July 2 (ANI/NewsVoir): Namma Homeopathy is an advanced No. 1 leading Homeopathic chain of clinics in Karnataka and Maharashtra with a vision of providing the best health care services and treatment through its advanced Immunogenic Miasmatic 6th Generation Homeop
Read More
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press
Read More
Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief
Updated : 4 years, 3 months ago IST
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
Read More
Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 stud
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
Read More
Covaxin trials on children show similar results as on adults, says expert
Updated : 4 years, 7 months ago IST
New Delhi [India], October 11 (ANI): As India's largest COVID-19 vaccination drive is underway, an AIIMS professor has claimed that the latest trials show that the safety and immunogenicity of India's indigenous COVID-19 vaccine--Covaxin--are almost the same in children, as adults above 1
Read More
Novavax begins early-stage trial for combined influenza, COVID-19 vaccines
Updated : 4 years, 8 months ago IST
Washington [US], September 8 (ANI): US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
Read More
Mix of Covishield, Covaxin yields better results: ICMR Study
Updated : 4 years, 9 months ago IST
New Delhi [India], August 8 (ANI): The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the COVID-19 vaccination programme, conducted on 18 people, has elicited better safety and immunogen
Read More
Zydus Cadila submits additional data to DCGI for its COVID-19 vaccine: Sou
Updated : 4 years, 10 months ago IST
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday.
Read More